title: Unusually prolonged rebound cataplexy after withdrawal of fluoxetine.
authors.affiliation: Neurology Department, University Hospital, Zurich, Switzerland.
authors.forename: Rositsa
authors.initials: R
authors.lastname: Poryazova
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Siccoli
authors.forename: Esther
authors.initials: E
authors.lastname: Werth
authors.forename: Claudio L
authors.initials: CL
authors.lastname: Bassetti
mesh_terms: D001933:Brain Stem / Q000187:drug effects / Q000503:physiopathology; D002385:Cataplexy / Q000139:chemically induced* / Q000503:physiopathology*; D004569:Electroencephalography / Q000187:drug effects; D004576:Electromyography; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009123:Muscle Hypotonia / Q000139:chemically induced / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000294:innervation / Q000503:physiopathology; D009290:Narcolepsy / Q000188:drug therapy* / Q000503:physiopathology; D017286:Polysomnography; D020923:REM Sleep Parasomnias / Q000139:chemically induced / Q000503:physiopathology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D013997:Time Factors
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors